{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:08:22Z","timestamp":1793747302415,"version":"4.6.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.ajo.2014.02.007","type":"journal-article","created":{"date-parts":[[2014,2,13]],"date-time":"2014-02-13T11:18:19Z","timestamp":1392290299000},"page":"1250-1257","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":101,"title":["Management of Thick Submacular Hemorrhage With Subretinal Tissue Plasminogen Activator and Pneumatic Displacement for Age-Related Macular Degeneration"],"prefix":"10.1016","volume":"157","author":[{"given":"Woohyok","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunir J.","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8894-1846","authenticated-orcid":false,"given":"Raj","family":"Maturi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arunan","family":"Sivalingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema A.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl D.","family":"Regillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen C.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ajo.2014.02.007_bib1","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S0002-9394(14)72107-5","article-title":"Variations in the clinical course of submacular hemorrhage","volume":"122","author":"Berrocal","year":"1996","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2014.02.007_bib2","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00006982-199616030-00001","article-title":"Natural history of subfoveal subretinal hemorrhage in age-related macular degeneration","volume":"16","author":"Avery","year":"1996","journal-title":"Retina"},{"issue":"1","key":"10.1016\/j.ajo.2014.02.007_bib3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0002-9394(14)75575-8","article-title":"Factors prognostic of visual outcome in patients with subretinal hemorrhage","volume":"109","author":"Bennett","year":"1990","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2014.02.007_bib4","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/0002-9394(82)90301-4","article-title":"Experimental subretinal hemorrhage in rabbits","volume":"94","author":"Glatt","year":"1982","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2014.02.007_bib5","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1001\/archopht.1991.01080050139046","article-title":"Fibrin directs early retinal damage after experimental subretinal hemorrhage","volume":"109","author":"Toth","year":"1991","journal-title":"Arch Ophthalmol"},{"issue":"11","key":"10.1016\/j.ajo.2014.02.007_bib6","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.ophtha.2004.07.023","article-title":"Surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: Ophthalmic findings: SST report no. 13","volume":"111","author":"Bressler","year":"2004","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.ajo.2014.02.007_bib7","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0002-9394(14)76571-7","article-title":"Intraoperative fibrinolysis of submacular hemorrhage with tissue plasminogen activator and surgical drainage","volume":"118","author":"Lewis","year":"1994","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajo.2014.02.007_bib8","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1001\/archopht.1990.01070090075043","article-title":"Subretinal hemorrhage management by pars plana vitrectomy and internal drainage","volume":"108","author":"Wade","year":"1990","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2014.02.007_bib9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0161-6420(91)32348-0","article-title":"Surgical removal of massive subretinal hemorrhage associated with age-related macular degeneration","volume":"98","author":"Vander","year":"1991","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.ajo.2014.02.007_bib10","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0161-6420(95)30858-5","article-title":"Submacular hemorrhage removal","volume":"102","author":"Lim","year":"1995","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.ajo.2014.02.007_bib11","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1016\/S0161-6420(99)90399-8","article-title":"Management of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacement","volume":"106","author":"Hassan","year":"1999","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.ajo.2014.02.007_bib12","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0002-9394(99)00239-1","article-title":"A study of the ability of tissue plasminogen activator to diffuse into the subretinal space after intravitreal injection in rabbits","volume":"128","author":"Kamei","year":"1999","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2014.02.007_bib13","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0002-9394(00)00734-0","article-title":"Pars plana vitrectomy, subretinal injection of tissue plasminogen activator, and fluid-gas exchange for displacement of thick submacular hemorrhage in age-related macular degeneration","volume":"131","author":"Haupert","year":"2001","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"10.1016\/j.ajo.2014.02.007_bib14","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.ophtha.2003.10.020","article-title":"Subretinal recombinant tissue plasminogen activator injection and pneumatic displacement of thick submacular hemorrhage in age-related macular degeneration","volume":"111","author":"Olivier","year":"2004","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ajo.2014.02.007_bib15","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/IAE.0b013e3180439bc9","article-title":"Analysis of forces acting upon submacular hemorrhage in pneumatic displacement","volume":"27","author":"Stopa","year":"2007","journal-title":"Retina"},{"issue":"1","key":"10.1016\/j.ajo.2014.02.007_bib16","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/IAE.0b013e31806e60db","article-title":"40 degrees gaze down position for pneumatic displacement of submacular hemorrhage: clinical application and results","volume":"28","author":"Lincoff","year":"2008","journal-title":"Retina"},{"issue":"8","key":"10.1016\/j.ajo.2014.02.007_bib17","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1097\/IAE.0b013e3181dd6d8a","article-title":"Prospective one-year study of ranibizumab for predominantly hemorrhagic choroidal neovascular lesions in age-related macular degeneration","volume":"30","author":"Chang","year":"2010","journal-title":"Retina"},{"issue":"6","key":"10.1016\/j.ajo.2014.02.007_bib18","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.ajo.2013.01.012","article-title":"Management of submacular hemorrhage secondary to neovascular age-related macular degeneration with anti-vascular endothelial growth factor monotherapy","volume":"155","author":"Shienbaum","year":"2013","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2014.02.007_bib19","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.ajo.2007.07.034","article-title":"Intravitreal bevacizumab therapy for neovascular age-related macular degeneration with large submacular hemorrhage","volume":"144","author":"Stifter","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2014.02.007_bib20","article-title":"Intravitreal anti-vascular endothelial growth factor for submacular hemorrhage from choroidal neovascularization","author":"Kim","year":"2013","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.ajo.2014.02.007_bib21","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1038\/eye.2008.267","article-title":"Management of extensive subfoveal haemorrhage secondary to neovascular age-related macular degeneration","volume":"23","author":"Sacu","year":"2009","journal-title":"Eye (Lond)"},{"issue":"4","key":"10.1016\/j.ajo.2014.02.007_bib22","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s004170050232","article-title":"Management of acute submacular hemorrhage using recombinant tissue plasminogen activator and gas","volume":"237","author":"Hesse","year":"1999","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajo.2014.02.007_bib23","first-page":"385","article-title":"Management of submacular hemorrhage with intravitreal sulfur hexafluoride: A pilot study","volume":"34","author":"Daneshvar","year":"1999","journal-title":"Can J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2014.02.007_bib24","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/00006982-200009000-00011","article-title":"Quantitative effect of intravitreally injected tissue plasminogen activator and gas on subretinal hemorrhage","volume":"20","author":"Hesse","year":"2000","journal-title":"Retina"},{"issue":"8","key":"10.1016\/j.ajo.2014.02.007_bib25","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/S0161-6420(01)00648-0","article-title":"Intravitreous injection of tissue plasminogen activator and gas in the treatment of submacular hemorrhage under various conditions","volume":"108","author":"Hattenbach","year":"2001","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ajo.2014.02.007_bib26","first-page":"28","article-title":"Treatment of submacular hemorrhage with low-dose intravitreal tissue plasminogen activator injection and pneumatic displacement","volume":"119","author":"Handwerger","year":"2001","journal-title":"Arch Ophthalmol"},{"issue":"9","key":"10.1016\/j.ajo.2014.02.007_bib27","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s00417-002-0516-5","article-title":"Tissue plasminogen activator plus gas injection in patients with subretinal hemorrhage caused by age-related macular degeneration: Predictive variables for visual outcome","volume":"240","author":"Schulze","year":"2002","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2014.02.007_bib28","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s00417-011-1649-1","article-title":"Pneumatic displacement of submacular hemorrhage with or without tissue plasminogen activator","volume":"249","author":"Mizutani","year":"2011","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2014.02.007_bib29","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/112067211002000305","article-title":"Pneumatic displacement of acute submacular hemorrhage with and without the use of tissue plasminogen activator","volume":"20","author":"Cakir","year":"2010","journal-title":"Eur J Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2014.02.007_bib30","first-page":"852","article-title":"Pneumatic displacement of a dense submacular hemorrhage with or without tissue plasminogen activator","volume":"28","author":"Yang","year":"2005","journal-title":"Chang Gung Med J"},{"issue":"3","key":"10.1016\/j.ajo.2014.02.007_bib31","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3928\/15428877-20090430-16","article-title":"Submacular combination treatment for management of acute, massive submacular hemorrhage in age-related macular degeneration","volume":"40","author":"Shah","year":"2009","journal-title":"Ophthalmic Surg Lasers Imaging"},{"issue":"3","key":"10.1016\/j.ajo.2014.02.007_bib32","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/01.iae.0000231544.43093.40","article-title":"Pneumatic displacement of submacular hemorrhage: Safety, efficacy, and patient selection","volume":"27","author":"Gopalakrishan","year":"2007","journal-title":"Retina"},{"issue":"4","key":"10.1016\/j.ajo.2014.02.007_bib33","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1167\/iovs.09-3582","article-title":"Vitreous VEGF clearance is increased after vitrectomy","volume":"51","author":"Lee","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.ajo.2014.02.007_bib34","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/IAE.0b013e3181e37884","article-title":"Intravitreous injection of bevacizumab, tissue plasminogen activator, and gas in the treatment of submacular hemorrhage in age-related macular degeneration","volume":"31","author":"Guthoff","year":"2011","journal-title":"Retina"},{"key":"10.1016\/j.ajo.2014.02.007_bib35","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2147\/OPTH.S8635","article-title":"Transconjunctival sutureless vitrectomy with tissue plasminogen activator, gas and intravitreal bevacizumab in the management of predominantly hemorrhagic age-related macular degeneration","volume":"4","author":"Arias","year":"2010","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.ajo.2014.02.007_bib36","first-page":"637","article-title":"Displacement of submacular hemorrhage associated with age-related macular degeneration using vitrectomy and submacular tPA injection followed by intravitreal ranibizumab","volume":"4","author":"Sandhu","year":"2010","journal-title":"Clin Ophthalmol"},{"issue":"14","key":"10.1016\/j.ajo.2014.02.007_bib37","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa054481","article-title":"Ranibizumab for neovascular age-related macular degeneration","volume":"355","author":"Rosenfeld","year":"2006","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.ajo.2014.02.007_bib38","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1056\/NEJMoa062655","article-title":"Ranibizumab versus verteporfin for neovascular age-related macular degeneration","volume":"355","author":"Brown","year":"2006","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ajo.2014.02.007_bib39","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ajo.2007.10.004","article-title":"Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER study year 1","volume":"145","author":"Regillo","year":"2008","journal-title":"Am J Ophthalmol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939414000701?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939414000701?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:09:53Z","timestamp":1757596193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939414000701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0002939414000701"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2014.02.007","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of Thick Submacular Hemorrhage With Subretinal Tissue Plasminogen Activator and Pneumatic Displacement for Age-Related Macular Degeneration","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2014.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}